Emerging Technology

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Meta Platforms, Inc. fka Facebook, Inc. between November 3, 2016 and October 4, 2021, inclusive of the important December 27, 2021 lead plaintiff deadline in the securities class action first filed by the firm. SO WHAT: If you purchased Facebook securities during the Class Period you may be entitled to compensation ...

-

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Meta Platforms, Inc. f/k/a Facebook, Inc. (NASDAQ: FB) ("Facebook") between November 3, 2016 and October 4, 2021, inclusive (the "Class Period"), of the important December 27, 2021 lead plaintiff deadline in the securities class action first filed by the firm.

SO WHAT: If you purchased Facebook securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Facebook class action, go to http://www.rosenlegal.com/cases-register-2176.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 27, 2021 . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Facebook misrepresented its user growth; (2) Facebook knew, or should have known, that duplicate accounts represented a greater portion of its growth than stated, and it should have provided more detailed disclosures as to the implication of duplicate accounts to Facebook's user base and growth; (3) Facebook did not provide a fair platform for speech, and regularly protected high profile users via its Cross Check/XCheck system; (4) despite being aware of their use of Facebook's platforms, the Company failed to respond meaningfully to drug cartels, human traffickers, and violent organizations; (5) Facebook has been working to attract preteens to its platform and services; and (6) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Facebook class action, go to http://www.rosenlegal.com/cases-register-2176.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm , on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/ .

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

FB
dgtl

DGTL Holdings Inc. Builds Strong Portfolio in Digital Media, Martech

NetworkNewsAudio DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) announces the availability of a broadcast titled, "Parabolic Growth Curve in Digital Media, Martech Sector Has Tech SPACS and Small Caps Booming."

To hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast

Keep reading... Show less
CSE:LXX

Lexaria Provides Strategic Update from CEO

Lexaria Bioscience Corp. (OTCQX:LXRP, CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces the following strategic update. (This is a shortened version of the full Strategic Update from the CEO. For the full version, please go to www.lexariabioscience.com/news/)

“Lexaria’s brightest days lie in the future, not in the past,” said Chris Bunka, Chief Executive Officer of Lexaria Bioscience Corp. Lexaria achieved many things during 2019 – indeed, management feels that it achieved virtually all that it had set out to accomplish and it was its best year ever from an operational perspective. Market forces caused a retreat in valuations across the sector to the point where Mr. Bunka commented that “It is my own opinion that Lexaria shares are dramatically undervalued – more so today than at any time in our history.”

Keep reading... Show less
CSE:LXX

Lexaria’s Appoints Former Altria Group Senior Executive and Operating Company Chief to Board of Directors

Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Brian Quigley to its board of directors. Mr. Quigley most recently spent 16 years at Altria Group, with 7 of those years spent as President and Chief Executive Officer for U.S. Smokeless Tobacco and Nu-Mark, Altria’s innovation company, during the time that the existing business relationship between Altria and Lexaria was negotiated.

Mr. Quigley is a 20-year Consumer Packaged Goods veteran of managing complex regulatory environments including for novel and innovative nicotine products, with additional deep experience with operations and marketing. In his time at Altria, Mr. Quigley spearheaded harm reduction strategies and worked to deliver results by creating change in the tobacco business in North America. Mr. Quigley has launched dozens of new products, created consumer-focused innovation strategies, and built businesses and cultures that deliver results.

Keep reading... Show less
CSE:LXX

Lexaria Bioscience Receives Cannabis R&D License from Health Canada

Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce that its subsidiary, Lexaria CanPharm ULC., has been issued cannabis Research and Development (“R&D”) license LIC-7NONT76UNW-2019 by Health Canada with a four-year term until August 9, 2023 unless renewed.

Lexaria’s new cannabis R&D license is effective immediately and will allow one of the country’s newest and most advanced formulation laboratories to conduct extensive investigatory work in both THC and CBD delivery using proprietary, optimized formulations and techniques. The laboratory was purpose-built, is permitted at local and federal levels, fully outfitted with equipment required to produce DehydraTECHTM infusions as well as including two different methodologies by which the Company can create nano-sized molecules when deemed beneficial and is currently operational.

Keep reading... Show less
CSE:LXX

Lexaria Bioscience Enters CBD License Agreement with Universal Hemp

Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces that it has entered a definitive 5-year agreement, via its subsidiary Lexaria Hemp Corp., to provide Lexaria’s patented DehydraTECHTM technology to Universal Hemp LLC, a B2B manufacturing company of high-performing hemp-derived bulk ingredients to the nutraceutical and consumer packaged goods industries, for utilization into many CBD-based food ingredients to be produced and sold across the USA immediately, and in Canada when regulations permit.

Competitive financial details including royalty rates remain confidential and undisclosed although the companies have agreed to disclose minimum payments over the life of the agreement of US$3,750,000.

Keep reading... Show less
DGTL Holdings Inc. Announces Closing of Financing

DGTL Holdings Inc. Announces Closing of Financing

Total Proceeds of $1,068,000 Satisfies Key Condition in Closing of the Proposed Merger with Engagement Labs

DGTL Holdings Inc. (TSXV: DGTL) (OTCQB: DGTHF) (FSE: A2QB0L) ("DGTL" or the "Company"), is pleased to announce the closing of a second and final tranche (the "Final Tranche") of its previously announced private placement offering of subscription receipts ("Subscription Receipts") and closing of its first tranche (the "First Tranche", together with the Final Tranche, the "Offering") on December 7, 2021. Under the Final Tranche, the Company issued 38 Subscription Receipts at an offering price of $1,000 per Subscription Receipt, for aggregate gross proceeds of $38,000, bringing the total number of Subscription Receipts issued pursuant to the Offering to 1,068 for aggregate total gross proceeds of $1,068,000. The completion of the Offering, satisfied a key condition to closing in the arrangement agreement between the Company and Engagement Labs Inc. (TSXV: EL) ("EL") dated August 11, 2021, as amended (the "Arrangement").

The gross proceeds of the Offering (the "Subscription Receipt Proceeds") are held by Garfinkle Biderman LLP ("Garfinkle"), in its capacity as subscription receipt agent, pursuant to the terms of a subscription receipt agreement entered into between DGTL and Garfinkle. Upon the satisfaction and/or waiver of certain escrow release conditions (the "Escrow Release Conditions") each Subscription Receipt will automatically be converted into a $1,000 principal amount Convertible Debenture (as defined below) and the Subscription Receipt Proceeds will be released. The Escrow Release Conditions shall include, without limitation, the completion of the Arrangement pursuant to a plan of arrangement and the delivery by DGTL of a notice to Garfinkle confirming such condition has been met.

The Convertible Debentures will bear interest at an annual rate of 7.00% payable in arrears in equal installments semi-annually. The Convertible Debentures will mature two years following the satisfaction of the Escrow Release Conditions (the "Maturity Date") as will be further set out in debenture certificates to be issued upon conversion of the Subscription Receipts. The principal amount of the Convertible Debenture will be convertible at the holder's option into common shares of DGTL (the "Conversion Shares") at any time prior to the Maturity Date at a conversion price of $0.30 per Conversion Share. Subject to the approval of the TSX Venture Exchange (the "TSXV"), in lieu of paying any interest accrued and payable in respect of the Convertible Debentures, DGTL may elect to settle such interest in Conversion Shares.

In connection with the Offering, the Company is required to pay finder's fees to eligible finders comprised of an aggregate of $49,000 in cash, and such cash finder's fees form part of the Subscription Receipt Proceeds and will be released to the finders upon satisfaction of the Escrow Release Conditions, and DGTL will issue 81,659 finder's warrants ("Finder's Warrants") upon satisfaction of the Escrow Release Conditions. Each Finder's Warrant entitles the holder thereof to purchase one common share of DGTL at a price of $0.40 for a period of 36 months following the date on which the Escrow Release Conditions are satisfied.

The Subscription Receipts and any underlying securities issued pursuant to the Final Tranche are subject to a statutory hold period of four months and one day from the date hereof.

ARRANGEMENT UPDATE

EL is in the process of preparing a joint information circular with DGTL in connection with their annual general and special meeting of shareholders to be held on February 14, 2022, to approve, among other items, the Arrangement.

ABOUT DGTL

DGTL acquires and accelerates transformative digital media, marketing and advertising software technologies, powered by Artificial Intelligence (AI). DGTL (i.e. Digital Growth Technologies and Licensing) specializes in accelerating commercialized enterprise level SaaS (software-as-a-service) companies in the sectors of content, analytics and distribution, via a blend of unique capitalization structures. DGTL is traded on the TSXV as "DGTL", the OTCQB exchange as "DGTHF", and the Frankfurt Stock Exchange as "A2QB0L". For more information, visit: www.dgtlinc.com.

HASHOFF LLC

As a wholly owned subsidiary of DGTL Holdings Inc., Hashoff LLC owns an enterprise level self-service CaaS (content-as-a-service) platform built on proprietary Artificial Intelligence and Machine Learning (AI-ML) technology. Hashoff empowers global brands by identifying, scoring, optimizing, engaging, managing, and tracking top-ranked digital content publishers for global brand marketing campaigns. Hashoff recently launched version 2.0 compatible for video-based applications (e.g. TikTok) and for conversion of social content to web advertisements via programmatic DSP distribution platforms.

Hashoff's active key customer portfolio includes DraftKings, Beam Suntory, Anheuser Busch-InBev, Dunkin Brands, Currency.com, Syneos Health, American Nurses Federation, Philippines Airlines, and channel partners Veritone, Centro, Wideout AQA, etc. Past clients are Nestle, Post Holdings Keurig-Dr. Pepper, Pizza Hut, Live Nation, The CW, Scribd, Novartis, etc.Learn more at https://dgtlinc.com/technology.[i]

CONTACTS - DGTL

John Belfontaine, Director
Email: IR@dgtlinc.com
Phone: +1 (877) 879-3485

Neither the TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to the satisfaction of closing conditions including, without limitation: (i) the ability of DGTL to complete the Escrow Release Conditions and (ii) the completion other closing conditions, including, without limitation, obtaining certain consents and TSXV approvals, the operation and performance of the DGTL and EL businesses in the ordinary course until closing of the Arrangement and compliance by DGTL and EL with various covenants contained in the arrangement agreement. In particular, there can be no assurance that the Arrangement will be completed.

Forward-looking statements are based on certain assumptions regarding DGTL and EL, including expected growth, results of operations, performance, continued approval of DGTL's and EL's activities by the relevant governmental and/or regulatory authorities, including the TSXV, and industry trends. While DGTL considers these assumptions to be reasonable, based on information currently available, they may prove to be incorrect. Readers are cautioned not to place undue reliance on forward-looking statements.

Forward-looking statements also necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; income tax and regulatory matters; the ability of DGTL and EL to implement their business strategies; competition; currency and interest rate fluctuations, the inability of DGTL to satisfy the Escrow Release Conditions; the inability of DGTL and EL to obtain the necessary approvals, including TSXV approval; the inability of DGTL and EL to complete the other with various covenants contained in the arrangement agreement; and other risks. Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect our expectations as of the date hereof, and thus are subject to change thereafter. DGTL disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. This news release has been approved by the board of directors of DGTL. Factors that could cause anticipated opportunities and actual results to differ materially include, but are not limited to, matters referred to above and elsewhere in DGTL's public filings and material change reports that will be filed in respect of the Arrangement which are and will be available on SEDAR.

Keep reading... Show less

The Water Institute at the University of Waterloo and BlackBerry Announce Partnership to Address Global Water-Related Challenges

New Innovation Research Challenge Seeks Proposals for Novel Applications of BlackBerry Technologies to Advance Progress Against UN Sustainable Development Goals

Building on a partnership spanning over three decades, BlackBerry Limited (NYSE: BB; TSX: BB) and the University of Waterloo 's Water Institute one of the world's top water research institutes, today launched a first-of-its-kind innovation research challenge for professors and students.

Keep reading... Show less

BlackBerry and PATEO Announce Strategic Collaboration to Deliver Integrated Digital Cockpit Solution Featuring BlackBerry IVY for the Chinese Market

Leading Chinese OEM to Participate in Pilot Project

BlackBerry Limited (NYSE: BB; TSX: BB) and PATEO a leading Internet of Vehicles (IoV) technology service & product provider in China, today announced a strategic collaboration that will see BlackBerry IVY™ integrated into PATEO's intelligent Digital Cockpit solution to develop data-driven in-vehicle services and drive new business opportunities in the Chinese market.

Keep reading... Show less

Meta to Announce Fourth Quarter and Full Year 2021 Results

- Meta Platforms, Inc. (NASDAQ: FB) announced today that the company's fourth quarter and full year 2021 financial results will be released after market close on Wednesday, February 2, 2022 .

Keep reading... Show less

BlackBerry to Participate in Upcoming Investor Events

BlackBerry Limited (NYSE: BB; TSX: BB) today announced its participation at the following virtual investor conferences in January 2022 :

Keep reading... Show less

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in Meta Platforms, Inc. f/k/a Facebook, Inc. with Losses of $500,000 to Contact the Firm

The Schall Law Firm a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Meta Platforms, Inc. fka Facebook, Inc. ("Facebook" or "the Company") (NASDAQ: FB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b -5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Keep reading... Show less

Latest Press Releases

Related News

×